At its October 2002 meeting, the board decided that if a medicinal product is to be eligible for purchase using Global Fund grants, it must meet various requirements. One of these is that if it is a “single- or limited-source product,” it must (a) have been found to be acceptable by the WHO-initiated UN Pilot Procurement Quality and Sourcing Project,…
